NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

56 hedge funds and large institutions have $1.02M invested in Navidea Biopharmaceuticals Inc. in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.

Holders
56
Holders Change
+3
Holders Change %
+5.66%
% of All Funds
1.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
6
Reduced
7
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Invesco
26
Invesco
Georgia
$4K -$240 -106 -6%
Citigroup
27
Citigroup
New York
$4K
CAG
28
Csenge Advisory Group
Florida
$4K +$4K +2,000 New
LFG
29
LifePlan Financial Group
Ohio
$3K
USAA
30
United Services Automobile Association
Texas
$3K
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$3K
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
$3K +$577 +250 +24%
LA
33
Lynch & Associates
Indiana
$2K
MCG
34
McCollum Christoferson Group
New York
$2K
HC
35
Hamilton Capital
Ohio
$2K
RJA
36
Raymond James & Associates
Florida
$2K
JCM
37
Jacobi Capital Management
Pennsylvania
$2K
PNC Financial Services Group
38
PNC Financial Services Group
Pennsylvania
$2K
SS
39
Simplicity Solutions
Minnesota
$2K +$2K +760 New
MAFM
40
Mid Atlantic Financial Management
Pennsylvania
$2K +$2K +788 New
Millennium Management
41
Millennium Management
New York
$2K +$2K +981 New
MWPCG
42
Measured Wealth Private Client Group
New Hampshire
$1K -$85 -50 -8%
ASN
43
Advisory Services Network
Georgia
$1K
CIBC World Market
44
CIBC World Market
Ontario, Canada
$1K
BO
45
BRR OpCo
Ohio
$1K
AWM
46
Aevitas Wealth Management
Massachusetts
$1K
SIS
47
Sound Income Strategies
Florida
$1K
B
48
Bailard
California
$1K
TW
49
TrinityPoint Wealth
Connecticut
$1K +$1K +500 New
HIIFS
50
Harel Insurance Investments & Financial Services
Israel
-$180K -39,000 Closed